PRESS RELEASE published on 02/26/2025 at 07:30, 1 year ago Evotec announces change in Management Board Evotec SE announces change in Management Board with Laetitia Rouxel stepping down as CFO and Paul Hitchin appointed as her successor. Rouxel to leave the Company on 31st March 2025. Hitchin brings over 20 years of finance leadership experience CFO Evotec SE Management Board Paul Hitchin Laetitia Rouxel
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Evotec collabore avec des entités coréennes sur de nouveaux traitements contre les maladies pulmonaires Collaboration Evotec Accorder Maladie Pulmonaire Développement De Traitement
BRIEF published on 01/22/2025 at 07:35, 1 year 2 months ago Evotec Collaborates with Korean Entities on Novel Lung Disease Treatments Collaboration Grant Evotec Lung Disease Treatment Development
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 2 months ago Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases Evotec SE receives US$ 4.5m grant from Korean Government to develop first-in-class therapeutic antibodies for lung diseases like asthma and idiopathic pulmonary fibrosis Evotec SE Grant Therapeutic Antibodies Lung Diseases Korean Government
BRIEF published on 12/11/2024 at 07:34, 1 year 3 months ago Evotec SE et Novo Nordisk lancent les projets LAB eN² pour la découverte de médicaments Evotec SE Découverte De Médicaments Novo Nordisk LAB EN² Maladies Cardiométaboliques
BRIEF published on 12/11/2024 at 07:34, 1 year 3 months ago Evotec SE and Novo Nordisk Launch LAB eN² Projects for Drug Discovery Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
PRESS RELEASE published on 12/11/2024 at 07:29, 1 year 3 months ago Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk Evotec SE announces selection of first projects for LAB eN² drug discovery accelerator with Novo Nordisk, focusing on cardiometabolic diseases from academic institutions Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 11/29/2024 at 07:36, 1 year 3 months ago Evotec annonce le départ de son directeur opérationnel et une restructuration interne Changement De Direction Evotec Médicaments Départ Du COO Restructuration Interne
BRIEF published on 11/29/2024 at 07:36, 1 year 3 months ago Evotec Announces COO Departure and Internal Restructuring Pharmaceuticals Management Change Evotec COO Departure Internal Restructuring
PRESS RELEASE published on 11/29/2024 at 07:31, 1 year 3 months ago Evotec announces change in Management Board Evotec SE announces the departure of Chief Operating Officer Dr Craig Johnstone effective December 31, 2024, with internal distribution of responsibilities. Management praises Johnstone's contribution and commitment Global Operations Chief Operating Officer Evotec SE Management Board Dr Craig Johnstone
Published on 03/23/2026 at 02:00, 4 hours 11 minutes ago FutureGen Industries Announces Open Market Investments
Published on 03/20/2026 at 13:30, 2 days 16 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/23/2026 at 03:35, 2 hours 36 minutes ago Deye 2026 Frankfurt Distributor & Partner Summit Concludes Successfully
Published on 03/22/2026 at 12:23, 17 hours 48 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 2 days 7 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 2 days 9 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 11 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 11 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 11 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
